Turnstone Biologics Corp. 10-K Cybersecurity GRC - 2025-03-28

Page last updated on March 31, 2025

Turnstone Biologics Corp. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2025-03-28 21:08:30 EDT.

Filings

10-K filed on 2025-03-28

Turnstone Biologics Corp. filed a 10-K at 2025-03-28 21:08:30 EDT
Accession Number: 0000950170-25-047111

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity Risk management and strategy We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and trade secrets, data we may collect about trial participants in connection with clinical trials, sensitive third-party data, business plans, transactions, and financial information (“Information Systems and Data”). Our information security, security management, and risk management functions help identify, assess and manage the Company’s cybersecurity threats and risks. Our information security security management, and risk management functions identify and assess risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example, automated tools, analyzing reports of cybersecurity threats and threat actors, evaluating our and our industry’s risk profile, conducting vulnerability assessments to identify vulnerabilities, conducting scans of the threat environment, and evaluating threats reported to us. Depending on the environment, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our Information Systems and Data, including, for example: incident detection and response, an incident response plan/policy, a vulnerability management policy, data encryption, network security controls, data segregation, asset management, tracking, and disposal, access controls, systems monitoring, employee training, risk assessments, implementation of security standards/certifications, cyber insurance, and a dedicated cybersecurity staff/officer. Our assessment and management of material risks from cybersecurity threats are integrated into the Company’s overall risk management processes. For example, the information security function works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business. We use third-party service providers to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats, including for example professional services firms (including legal counsel), cybersecurity consultants, and cybersecurity software providers. We also use third-party service providers to perform a variety of functions throughout our business, such as application providers. We manage cybersecurity risks associated with our use of these providers using measures including risk assessments, reviewing their security assessments, reviewing their written security program, audits, and reports. Depending on the nature of the services provided, the sensitivity of the Information Systems and Data at issue, and the identity of the provider, our vendor management process may involve different levels of assessment designed to help identify cybersecurity risks associated with a provider and impose contractual obligations related to cybersecurity on the provider . For a description of the risks from cybersecurity threats that may materially affect the Company and how they may do so, see our risk factors under Part 1. Item 1A. Risk Factors in this Annual Report on Form 10-K, including “Our internal information technology systems, or those of our third parties with whom we work, may fail or suffer security breaches, loss or leakage of data and other disruptions, which could result in a material disruption of our development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability, and could adversely affect our business, results of operations and financial condition”. 76 Governance Our board of directors addresses the Company’s cybersecurity risk management as part of its general oversight function. The audit committee within the board of directors’ is responsible for overseeing Company’s cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats. Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our contracted IT Director, who has over 24 years of IT management experience for public companies including Synergy Pharmaceuticals, Inc. Our information security function is responsible for hiring appropriate personnel, helping to integrate cybersecurity risk considerations into the Company’s overall risk management strategy, and communicating key priorities to relevant personnel. Our Principal Financial and Accounting Officer and information security function are responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports. Our response process to cybersecurity incidents is designed to escalate certain incidents to members of management depending on the circumstances, including the Principal Financial and Accounting Officer. Our Principal Financial and Accounting Officer and others work with the Company’s incident response team to help the Company mitigate and remediate cybersecurity incidents of which they are notified. In addition, the Company’s incident response policy includes reporting to the board of directors committee responsible for certain cybersecurity incidents. The board committee receives periodic reports from our information security function (including our IT Director) concerning the Company’s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The board committee also has access to various reports, summaries or presentations related to cybersecurity threats, risk and mitigation.


Company Information

NameTurnstone Biologics Corp.
CIK0001764974
SIC DescriptionBiological Products, (No Diagnostic Substances)
TickerTSBX - Nasdaq
Website
Category
Emerging growth company
Fiscal Year EndDecember 30